Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Jan 8.
Published in final edited form as: J Recept Signal Transduct Res. 2010 Sep 16;30(6):420–429. doi: 10.3109/10799893.2010.513991

Protein tyrosine nitration in cellular signal transduction pathways

Vasily A Yakovlev 1, Ross B Mikkelsen 1
PMCID: PMC4287369  NIHMSID: NIHMS652738  PMID: 20843272

Abstract

How specificity and reversibility in tyrosine nitration are defined biologically in cellular systems is poorly understood. As more investigations identify proteins involved in cell regulatory pathways in which only a small fraction of that protein pool is modified by nitration to affect cell function, the mechanisms of biological specificity and reversal should come into focus. In this review experimental evidence has been summarized to suggest that tyrosine nitration is a highly selective modification and under certain physiological conditions fulfills the criteria of a physiologically relevant signal. It can be specific, reversible, occurs on a physiological time scale, and, depending on a target, can result in either activation or inhibition.

Keywords: Nitric oxide, tyrosine nitration, peroxynitrite, superoxide, uncoupling

Introduction

Reactive nitrogen species (RNS) as signaling molecules have been studied in terms of four primary mechanisms: (1) binding to metal centers; (2) nitrosylation of thiol and amine groups; (3) nitration of Tyr; and (4) oxidation of thiols (both Cys and Met). The most extensively studied is NO• binding to the heme group of soluble guanylate cyclase, stimulating cyclic guanosine monophosphate production and activation of protein kinase G. NO• also binds to the heme group of cytochrome c oxidase with consequential inhibition of cytochrome c oxidase activity. This is one proposed mechanism of mitochondrial electron transport regulation that minimizes mitochondrial reactive oxygen species (ROS) generation (1). More recent studies on RNS-dependent signal transduction mechanisms have focused on protein modifications. Two protein modifications, in particular, nitrosylation of thiols to produce S-nitrosothiol and nitration of Tyr residues to produce nitroTyr, are being intensely investigated in this context.

S-nitrosylation has been shown in numerous investigations to fulfill the criteria of a physiologically relevant signal in that it can be specific, reversible, occurs on physiological time scale, and depending on a target, can result in either activation or inhibition (2,3). Stamler and associates propose that S-nitrosylation of protein Cys residues is the prototypic redox-based post-translation mechanism comparable to protein phosphorylation (4). Transcription factors, caspases, receptor tyrosine kinases and protein tyrosine phosphatases as well as a number of other proteins are reversibly S-nitrosylated after the treatment of cells with NO• donors or activation of signal transduction pathways (58). Caspases when S-nitrosylated at their active site Cys are inhibited (6,7,9,10). S-nitrosylation of proteins such as protein tyro-sine phosphatases and their inhibition has been shown to intersect with other signal transduction pathways, e.g. receptor tyrosine kinases (5,11).

The biological signficance of Tyr nitration, on the other hand, remains ill-defined. However, accumulating data show a strong link between protein Tyr nitration and the mechanisms involved in formation of many pathological conditions and diseases: post-radiation response, acute and chronic inflammation, acute and chronic rejection of the allograft, chronic hypoxia, tumor vascularization and microenvironment, atherosclerosis, myocardial infarction, chronic obstructive pulmonary disease, diabetes, Parkinson's disease, Alzheimer's disease, and others (1229). For this reason researchers are looking at new pharmacological strategies of inhibiting protein Tyr nitration as an additional type of treatment for many pathological conditions (3039). As discussed below there is also accumulating experimental evidence that protein Tyr nitration can under certain conditions have the specificity necessary for normal physiological cellular signaling pathways. This review will focus its attention on this latter argument that specific protein Tyr nitration fulfills the criteria of a signal transducing mechanism.

In vitro analysis of protein Tyr nitration

In most cases the amount of Tyr nitration of an individual protein obtained under endogenous conditions is very low. Thus to examine sites of nitration, investigators use RNS donors and purified proteins to maximize yield of nitration. Interpretation of results from these in vitro experiments requires consideration of the type and concentration of RNS donor used and ultimately in vivo validation under appropriate environmental conditions.

Selectivity in which Tyrs are nitrated can depend on the type of RNS (or RNS donors). For example, glutamate dehydrogenase is nitrated by both Hemin–H2O2–NO2 and the peroxynitrite (OONO) donor, SIN-1 (40). Mass spectrometric analyses of the nitrated enzyme demonstrated completely different Tyr nitration patterns in the same protein: Tyr262 and Tyr471 after nitration by Hemin–H2O2–NO2 and Tyr401 and Tyr493 after nitration by SIN-1. Another example is seen in comparing ONOO and tetranitromethane (TNM)-dependent Tyr nitration of cytochrome c (41). The main reaction products of cyto-chrome c obtained with ONOO are two mono-nitrated protein molecules, one with nitroTyr97 and the other with nitroTyr74. Based on abundance, Tyr97 is preferentially nitrated by ONOO. TNM treatment of cyto-chrome c, on the other hand, generates three products: two mono-nitrated cytochrome c species (nitroTyr74 or nitroTyr67) and a single di-nitrated cytochrome c with both Tyr67 and Tyr74 nitrated. Other investigators have reported TNM-dependent nitration of cytochrome c at Tyr67 alone (42). Similar divergent results are found for glycogen phosphorylase b in comparing Tyr nitration by ONOO and TNM. Low doses of ONOO (<50μM) nitrate glycogen phosphorylase b on Tyr613 with five more Tyrs (Tyr83, Tyr84, Tyr90, Tyr74, and Tyr75) nitrated at higher ONOO concentrations (>75 μM) (43). In contrast, TNM nitrates glycogen phosphorylase b on Tyr75, Tyr203, Tyr262, Tyr280, Tyr403, Tyr552, and Tyr647 (44).

Lennon and co-investigators proposed one explanation for the differential nitration obtained with ONOO and TNM based on their studies with prion protein isoforms (45). TNM, unlike ONOO, is soluble in organic solvents, and thus in principle more readily reacts with buried Tyr residues than ONOO. This may be true for the prion protein, however this does not account for the results comparing the nitration patterns of other proteins with these RNS donors (41,42,44).

The studies cited above not only reveal differences in nitration patterns depending on RNS donor but also on the concentration of donor. Other examples include mammalian aldolase A and the tumor suppressor protein p53. Peroxynitrite in the concentration range of 100–200 μM nitrates mammalian aldolase A at Tyr243, Tyr342, and Tyr363. Increasing the ONOO concentration to 500 μM results in nitration of one additional Tyr residue, Tyr222 (46). Treatment of cells with the NO•-donor DETA NONOate at concentrations of 20–50 μM that mimic a chronically low inflammatory state nitrates p53 protein on Tyr327. However, at higher DETA NONOate concentrations (≥200 μM) additional Tyr(s) of p53 become nitrated (47). As will be discussed below, not only is donor concentration important in selectivity but also the exposure time of the substrate with donor (28).

In vivo validation is ultimately required to determine the physiological significance of the nitrative event. Some proteins are equivalently nitrated in vitro and in vivo although this is often not the case especially at extremes of RNS concentration and time. For example, Tyr nitration analysis of human nitric oxide synthase-2 (NOS2) in vitro (by ONOO) and in muscle samples from a subset of three patients with sepsis showed identical nitrated Tyrs (48). Mass spectrometry demonstrated nitration of only 4 Tyrs among the 31 Tyrs residues present in NOS2. Nitrated Tyr was located at positions 299 and 336 in the three patients examined. In addition, Tyr446 was nitrated in one patient, whereas Tyr698 was nitrated in another patient. Those 4 Tyrs (located at positions 299, 336, 446, and 698) were nitrated when NOS2 was incubated with ONOO in vitro.

In previous work, we (49) showed that IκBα was equally nitrated on Tyr181 and Tyr305 in vivo (by ionizing radiation-dependent activation of constitutive NOS activity in intact cells) as well as in vitro with lysates from cells overexpressing IκB (by bolus ONOO). However, in a study on p53 nitration following treatment of cells with ionizing radiation or with low doses of an NO• donor mimicking the inflammatory microenvironment a clear difference was observed between these treatments and in vitro nitration with ONOO or in vivo with excessively high doses of a NO• donor (47). p53 was selectively nitrated on Tyr327 in the tetramerization domain following the radiation exposure or at low NO• donor concentrations but treatment with ONOO in vitro was less selective with at least two additional Tyrs nitrated including one in the DNA binding domain. Experiments using NO• donors at different concentrations or radiation and with cells expressing p53 molecules differing in Tyr mutant status demonstrated that selective nitration of p53 had significant consequences in terms of gene expression profiles.

Aslan et al. (2003) compared Tyr nitration of actin in liver and kidney homogenates from sickle cell disease mouse with in vitro nitration by ONOO (50). Three of 15 actin tyrosine residues were nitrated (Tyr91, Tyr198, and Tyr240) in vivo. In vitro treatment with ONOO modified four residues (Tyr53, Tyr198, Tyr240, and Tyr362) with nitration of Tyr362 not consistently observed in some experiments.

In vivo, the skeletal muscle creatine kinase of untreated 34-month old rats is nitrated at both Tyr14 and Tyr20 but of none of the other seven Tyr residues at positions 39, 82, 125, 140, 173, 174, and 279 (51). In contrast, in vitro exposure of creatine kinase to ONOO nitrates exclusively Tyr82. These investigators suggested that one or more of the following factors likely cause these distinctly different patterns. One mechanism may result from proteosome degradation of specific nitrated isoforms of creatine kinase. Nitrated proteins can be preferential targets of proteosome proteolysis (52). A nitrating agent may generate nitroTyr predominantly at one specific location in the protein and negligible yields of nitroTyr at other positions. Nevertheless, protein isoforms containing the nitroTyr at these other positions may accumulate with age if they are resistant to degradation, and at the same time, the protein isoforms containing nitroTyr at the predominant target Tyr residue are susceptible to degradation. Alternatively, ONOO might not be the (only) nitrating agent in vivo. For example, Zeng et al. (2005) investigated myeloperoxidase (MPO)-mediated apoA-I nitration and chlorination in vitro and in vivo and attempted to relate the degree of site-specific modifications to loss of apoA-I lipid binding and cholesterol efflux functions (53). Of the seven Tyr residues in apoA-I, Tyr192, Tyr166, Tyr236, and Tyr29 were nitrated in MPO-mediated reactions. The favored modification site following exposure to MPO-generated oxidants was Tyr192. MPO-dependent nitration proceeded with Tyr166 as a secondary site and with Tyr236 and Tyr29 modified only minimally. A parallel study of apoA-I in human atherosclerotic tissue revealed its nitration at the MPO-preferred sites, Tyr192 and Tyr166. In contrast, in vitro nitration with 100 μM ONOO generated nitroTyr at three Tyr residues: Tyr166, Tyr8, and Tyr236. The remaining Tyr residues were detected in these analyses as exclusively in the un-nitrated form.

There is also the potential for a time-dependent selectivity for in vivo Tyr nitration. Sharov et al. (2006) identified age-dependent post-translational modifications of skeletal muscle glycogen phosphorylase b isolated from F1 hybrids of Fisher 344 × Brown Norway rats (54). This study revealed the accumulation of nitroTyr on Tyr113, Tyr161, and Tyr573. Although nitration of Tyr113 was detected for both young and old rats, nitroTyr at positions 161 and 573 was identified only for enzyme isolated from aged 34-months old rats. The in vitro reaction of ONOO with glycogen phosphorylase b resulted in the nitration of Tyrs, 51, 52, 113, 155, 185, 203, 262, 280, 404, 473, 731, and 732. Thus, the in vitro nitration conditions only mimic the nitration of a single Tyr residue observed in vivo, suggesting alternative mechanisms controlling the nitration and accumulation of nitroTyr in vivo.

In summary to this section, it is apparent that in vitro experiments with isolated proteins can provide some evidence for potential nitration sites but this evidence can also be misleading both positively and negatively. The use of RNS donors with intact cells while under some circumstances an improvement can also be misleading since as discussed below it does not always recreate the subcellular RNS gradients that are generated in vivo. This may be especially important in identifying low abundance proteins involved in signal transduction pathways and whose activities may be subtly modulated by Tyr nitration. A clearer, more in depth understanding of those physiochemical and microenvironmental factors that determine specificity in Tyr nitration is needed.

Protein structure and Tyr nitration

There is selectivity in Tyr nitration, since as shown above not all proteins in a tissue under analysis are nitrated nor are all Tyrs of a nitrated protein nitrated. As discussed by several investigators (5559), one would expect a relatively high degree of Tyr nitration given the moderate hydrophilic character of Tyr and its relatively high degree of surface exposure (only 15% of Tyr residues are at least 95% buried). However, that this is not the sole criterion is born out by studies of human serum albumin, the most abundant plasma protein. Only 2 of its 18 Tyrs are nitrated by ONOO in vitro. In plasma samples from patients with acute respiratory distress syndrome 5 proteins not including serum albumin are nitrated. These results as do many of the studies cited above imply specificity especially in vivo.

No consensus primary sequence for Tyr nitration has been defined. A recent analysis of amino acid sequences of proteins nitrated both in vitro and in vivo (aged rat tissues) suggests three common features: (1) one or more acidic residues near the nitratable Tyr, (2) nearby turn-inducing amino acids, Pro or Gly, and (3) mostly exclusion of sulfur containing Met and Cys. An earlier analysis of 10 identified nitrated proteins suggested the following consensus sequence, H-X-[DE]-H-X(2,3)-H(2)-X(2,4)-Y, where H is any hydrophobic amino acid and X is any amino acid (59). The increased frequency of hydrophobic amino acids near the target Tyr is suggested to be consistent with the observation of apparent selective nitration of Tyrs in transmembrane domains of membrane proteins. A difficulty in defining a consensus sequence based on comparing linear peptide sequences containing nitrated Tyrs is that the sequences of non-nitrated Tyrs are not simultaneously compared. This is seen in another study on nitrated proteins from rat brains using mass spectrometry to identify and compare both nitrated and non-nitrated Tyr containing peptide sequences in terms of primary sequence and three dimensional structures near the nitrated Tyr for the proteins of known high-resolution structure (60). This analysis as did previous studies demonstrated an in vivo preference for nitration of surface exposed Tyrs in loops and also a modest preference for an Asp or Glu near the nitrated Tyr. However, in contrast to the earlier investigations, most all peptide sequences containing nitroTyr also contained a Cys or Met suggesting that these amino acids do not inhibit Tyr nitration in vivo. Furthermore, this analysis of in vivo nitrated proteins also revealed the overwhelming presence of a basic amino acid (Lys or Arg) in the 9 amino acid peptide window in nitrated versus non-nitrated Tyr peptides.

Souza et al. (58) made an interesting suggestion concerning specificity based on pulse radiolysis experiments with lysozyme and a two step model for Tyr nitration. The initial step in Tyr nitration is the oxidation of the phenolic ring of Tyr to yield the one-electron oxidation product, Tyr•. The second step involves the termination reaction of one radical Tyr• with another, •NO2. The diffusion limiting reaction of NO• with superoxide (O2) generates ONOO that after protonation to peroxynitrous acid yields •OH and •NO2. At physiological levels of CO2, the nitrosoperoxocarbonate (ONOOCO2) forms which homolyzes to •NO and CO3. The carbonate radical, CO3, is a much more effective one-electron oxidant than the hydroxyl radical, •OH, and thus it is observed that nitration yields are higher in the presence of CO2. The pulse radiolysis experiments initially show oxidation of Trp yielding an indolyl radical and subsequently by intramolecular electron transfer resulted in the oxidation of Tyr to Tyr•. As suggested by Souza et al. (58), a stabilized Tyr• could be prone to reaction with •NO2 far from the site of the initial oxidation step. Molecular interactions that stabilize the Tyr• or the nitrating species would presumably provide specificity to the final nitration step. A basic amino acid in close proximity suggests the possible involvement of electrostatic interactions stabilizing nitrating anions such as ONOOCO2.

Specificity in the nitration process may not only be derived from close proximity as defined by the primary amino acid sequence but from higher protein structure levels. An example of this is seen in the consensus sequence for S-nitrosylation. Analysis of the primary sequences of S-nitrosylated proteins and the realization that acid-base catalysis alternatively promotes protein S-nitrosylation and denitrosylation suggest a degenerate consensus sequence, (G,S,T,C,Y,N,Q,)(K,R,H,D,E,) C(D,E) (61). The acid-base motif does not have to reside in the linear primary sequence but can be generated from the tertiary structure of the protein (62). For example, replacement of the acidic (Asp355) or basic (Arg357 and Arg363) amino acids located in the vicinity of Cys121 by Ser leads to a marked reduction in the ability of NO• to S-nitrosylate and inactivate hepatic methionine adenosyltransferase.

We have examined two proteins nitrated in vivo by mild oxidative/nitrosative stresses that may provide some clues as to long distance interactions that determine specificity in the nitration process or its consequences (47,49). IκBα, the inhibitory protein of the transcription factor nuclear factor-κB (NF-κB) is nitrated on 2 of 8 Tyrs, Tyr181, and Tyr305, after activation of the endogenous NOS. The crystallographic structure of the complex shows the fingers 3/4, 4/5, and 5/6 of IκBα contact the p50 subunit of NF-κB. Tyr181 and Asn182 extending from finger 3/4 have multiple contacts with p50. Tyr181 forms hydrogen bonds with p50 Lys252 and Arg258, π-stacks with Tyr351, and makes multiple van der Waals contacts with Ala260, Pro327, and Leu349 of p50. Using a software program to calculate on an atom-by-atom basis the enthalpic interactions of Tyr181 with all other atoms within 8 Å, an in silico nitration of Tyr181 induced signifi-cant destabilizing changes in these interactions of about 3 kcal/mol. In contrast, the “nitration” enhanced Tyr181 interactions with other IκBα residues within 8 Å consistent with a net stabilizing effect. Major contributions to this positive interaction are the acid/base and hydrogen bond interactions of the nitro-group with Arg140 of IκBα. The role of Tyr305 nitration is not clear since the available crystallographic structures of IκBα use a truncated version of the inhibitor protein. However, Tyr305 is in the PEST domain of IκBα and thus may be involved in modulation of IκBα stability in vivo.

Under similar mild oxidative/nitrosative conditions the tumor suppressor protein, p53, is nitrated in vivo on 1 of 9 Tyrs, Tyr327 in the tetramerization domain (47). The consequences of this nitrative event as demonstrated by combined functional, biochemical and molecular approaches is enhanced oligomerization of p53 and its transcriptional activation. A transcriptional analysis using p53 specific mRNA microarrays revealed that selective nitration of Tyr327 at low NO• donor concentrations resulted in an mRNA expression spectrum very different from that obtained with ionizing radiation or at very high NO•. An in silico structural analysis based on the tetrameric p53 structure demonstrated increased stability of the tetramer by interaction of the nitrated Tyr327 of one monomer with Arg333 of an adjacent monomer. Thus, this same Arg-Tyr/nitroTyr interaction appears to play an important role but with very different consequences compared to IκBα/NFκB—enhanced protein-protein interactions. The significance of this nitroTyr-Arg interaction in broader terms will depend on future studies relating protein structure and the nitrative process.

The above discussion is limited to non-metalloproteins. With metalloproteins containing a metal center or heme group different nitration mechanisms are involved. These are discussed in more detail by Souza et al. (47,49,58). With these proteins the metal center promotes nitration of an adjacent Tyr. For example with manganese super-oxide dismutase (Mn-SOD), one mechanism proposes that a Mn-O complex oxidizes Tyr34 to •Tyr34 which then reacts with •NO2 to form the nitrated Tyr.

Subcellular location of the target protein and sites of RNS generation

Specificity in nitration of specific proteins can also result from the subcellular locations of the NO• generators. As discussed in more detail below, the catalytic cycle of all three isoforms of NOS can become uncoupled with the result that NOS no longer generates NO• but superoxide anion, •O2. The subcellular locations of the different isoforms differ with NOS1 predominantly localized to the plasma membrane although some investigators propose a mitochondrial like NOS1; NOS2 is found in the cytosol, peroxidase-containing secretory granules and peroxisomes; and NOS3 associates with the Golgi, endoplasmic reticulum, and plasma membrane caveolae. There are also other less defined mechanisms for cellular NO• generation including the cytoplasmic enzyme, alde-hyde oxidase (63), and a nitrite reductase activity found in mitochondria (64). Because NO• is a relatively stable free radical and can diffuse substantial cellular distances, localized formation of nitrating RNS may also depend on the subcellular location of ROS generators. Especially prominent are the mitochondrial electron transport chain and plasma membrane caveolae NADPH oxidase as well as specialized organelles such as peroxisomes.

A careful high-resolution immunoelectron microscopy study evaluated the subcellular distribution of Tyr-nitrated proteins in different cells and tissues (65). This analysis revealed that endogenous nitrated proteins distributed differently depending on cell type but that for the most part localized in compartments in close proximity to the high NO• producing NOS2 and enzymes involved in ROS generation. Because this study only evaluates high abundance nitrated proteins, more subtle changes in protein nitration due to low levels of NO• generated by the constitutive NOS isoforms, NOS1 and NOS3, would not necessarily have been detected. This is important because, as described below, a number of low abundance proteins involved in signal transduction pathways are nitrated under very mild oxidative/nitrosative conditions. For example, binding of caveolin-1 to NOS3 inhibits NOS3 activity in endothelial cells and disruption of this interaction leads to hyperactive NOS3 and increased protein Tyr nitration including protein kinase G (66). Nitration of protein kinase G inhibits its activity and in lungs this inhibition can result in pulmonary hypertension. Alternatively, nitration of a critical high abundance protein can be limited to a subcellular compartment minimizing cellular damage but permitting propagation of a signal throughout the cell. An example of this is seen with the mitochondrial enzyme, Mn-SOD, a protein nitrated in rejected human kidney allografts and in tissue culture cells after exposure to ionizing radiation (26,67). For rejected human allograft tissue, the chronic oxidative/nitrosative stress results in significant nitration and inhibition of mitochondrial Mn-SOD enzymatic activity. Inactivation of Mn-SOD increases the lifetime of •O2 and hence formation of ONOO from NO• by a “positive feedback cycle” (67). Tyr nitration of Mn-SOD is also observed after exposing cells to ionizing radiation. However, inhibition in enzymatic activity is not detected, possibly because only a small fraction of a very abundant cellular protein is nitrated (67). Nonetheless, even if enzyme inhibition is limited to a single mitochondrion within a cell and not detectable by standard assay, significant biological effects can still accrue. This is because of intermitochondrial propagation of an oxidative signal from one mitochondrion to adjacent mitochondria via a reversible permeability transition, e.g. (6770). Thus a potentially lethal oxidative event can be limited to a single mitochondrion amongst hundreds within a cell while at the same time initiating and amplifying reversible cellular signaling pathways.

Regulation of NOS activity by uncoupling of the NOS catalytic cycle

An important discovery about the enzyme activity of all NOS isoforms is that it can become uncoupled and as a consequence shift producing NO• to generating ONOO or O2. The catalytic cycle of all NOS isoforms involves the transfer of electrons coupled with the oxidation of arginine with the cofactor tetrahydrobiopterin (BH4) donating electrons to the ferrous-dioxygen complex to initiate oxidation. If BH4 is limiting which can be the case under chronic inflammatory conditions, coupling becomes less efficient and more O2 is generated. Under these conditions NOS have been termed “peroxynitrite synthases” (7173). This further amplifies the uncoupling with the generation of more powerful oxidants thus produced (•NO2, •CO3, •OH) further depleting BH4.

NOS activity can also be uncoupled with the generation of •O2 by depleting the substrate arginine (74). Physiologically this may not be relevant except under conditions of high arginase expression or elevated levels of endogenous inhibitors such as the asymmetric dimethlyarginines. Previous studies (75,76) have demonstrated that elevated cytoplasmic arginase expression uncouples NOS activity in endothelial cells contributing to endothelial dysfunction and redirects arginine metabolism to the formation of polyamines and l-proline critical for smooth muscle proliferation and collagen synthesis. Under hypoxic conditions, elevated arginase expression is critical for proliferation of human pulmonary microvascular endothelial cells. Increased arginase activity also sensitizes NOS activity to inhibition by asymmetric dimethyl arginines (ADMA) and l-NMMA (NG-monomethyl- l-arginine). These l-arginine analogues are produced from the proteolytic degradation of proteins containing methylated residues(77). ADMA and l-NMMA are inhibitors of all three NOS. ADMA is degraded by DDAHs (dimethylarginine dimethylaminohydrolases), levels of ADMA/l-NMMA are critical factors in modulating angiogenesis.

Regardless of the mechanism of uncoupling, the consequences may represent a critical switching mechanism for cell growth. When fully coupled, the primary product of NOS is NO• and downstream signaling is dominated by NO• dependent pathways including soluble guanylate cyclase/protein kinase G and S-nitrosylation. Uncoupled NOS on the other hand produces potent oxidants such as ONOO and •OH initiating different downstream signaling. Depending on their levels and cellular context, these latter oxidants are not necessarily cytotoxic but may actually stimulate cytoprotective mechanisms, e.g. NF-κB (49).

Reversibility of protein Tyr nitration

An important characteristic of all regulatory signal transduction mechanisms is reversibility. With respect to phosphorylation this is accomplished by apposing kinase and phosphatase activities. Proteolysis of post-translationally modified proteins is another mechanism that can irreversibly modulate a pathway and this is commonly seen in change in state signaling as in cell cycle transitions and proteolysis of cyclins. With respect to nitrated proteins there is evidence for both “denitrase” activity and enhanced proteolysis of nitrated proteins.

Early studies by Murad and associates identified a “denitrase” activity in lysates from spleen, liver and cultured macrophages(78,79). By the classical protein criteria of heat and trypsin sensitivities, the denitrase was a protein with substrate specificity. For example, the denitrase activity from activated macrophages denitrated histone H1.2 but not CuZn-SOD. The activity was inducible in macrophages by lipopolysaccharide (LPS). Subsequent studies by other investigators also demonstrated a denitrase activity in LPS-stimulated macrophages that was selective for nitrated calmodulin, glutamine synthetase and the human smooth muscle calcium channel, hCa(v)1.2b (7882). Nitration and as a consequence inhibition of Src kinase phosphorylation of the calcium channel protein was reversed by treating the channel protein with the LPS-activated macrophage lysate. In the one study in which it was examined, no intermediate stage involving formation of amino-Tyr was observed in the apparent denitrase mechanism. All the above studies controlled for possible proteolysis with appropriate loading controls and, because conditions were used to yield maximal levels of nitrated protein, it is unlikely that proteolysis of a small amount of nitrated could explain the results.

Other studies in which time courses of nitration/ denitration of specific proteins were followed are also consistent with a denitration mechanism. Mn-SOD, NF-κB inhibitor protein, IκBα, the tumor suppressor protein, p53, and a number of undefined proteins are transiently nitrated after an exposure to a clinically relevant dose of radiation (47,49,67). With respect to IκBα and p53 that were studied in detail, western blot analysis with and without a proteosome inhibitor suggests that selective proteolysis of the nitrated proteins could not account for the apparent denitration. However, only about 5–10% of each protein was nitrated leaving open the possibility that the protein analysis was insufficiently sensitive to detect rapid turnover of the nitrated proteins. The frequency of transient nitration of IκBα after radiation corresponded to that observed for tumor necrosis factor dependent IKK-dependent phosphorylation (83). Both nitration and phosphorylation of IκBα result in the dissociation of IκBα from NF-κB and transcriptional activation although the IKK-dependent transcriptional response was much more robust. One explanation for this difference in magnitude of the transcriptonial responses is probably that phosphorylation triggers ubiquitination and proteolysis of IκBα whereas the nitration mechanism did not.

Nitration and denitration of mitochondrial proteins have also been studied (46,84). With highly purified rat liver mitochondria, nitration of several mitochondrial proteins decreased within 5 min of hypoxia/anoxia and was completely blocked by 20 min with no apparent loss of proteins as detected by 2D gel electrophoresis and western blot. Moreover, nitration of these same proteins subsequently recovered within minutes of re-oxygenation. If mitochondria were incubated with l-arginine under oxygenated conditions, there was a progressive increase in the nitrated proteins. No increase or decrease was observed when the mitochondria were incubated with non-metabolizable d-arginine and d-arginine did not inhibit the recovery in nitrated proteins upon re-oxygenation. These results suggest that the mitochondria have a mechanism for NO• generation independent of arginine. A number of the proteins nitrated and denitrated were identified by mass spectroscopy and shown to be involved in electron transport and the TCA cycle. These proteins are nuclear encoded so that it is difficult to argue for a proteolysis/ resynthesis cycle to explain the results. As concluded by these investigators, the nitration/denitration cycling observed with these mitochondrial proteins has many of the characteristics of a signaling pathway including reversibility, responsiveness on a physiological time scale and selectivity.

Enhanced proteolysis and resynthesis of nitrated proteins represents an alternative mechanism for nitration reversibility (55,56,58,85). This mechanism is also seen with phosphorylation of some proteins, e.g. cyclins and IκB. Generally speaking, oxidative modification of proteins increases their susceptibility to proteolysis. Nitrated proteins appear to be more rapidly degraded by proteo-some activity but not by calpain or proteases sensitive to a serine protease inhibitor. Most of these studies used ONOO to modify the target proteins and thus cannot rule out oxidation of other amino acids as contributing to enhanced protein degradation. One exception is the study with CuZn-SOD where only Tyr108 was nitrated without any other amino acid modification as validated by mass spectrometry. Nitrated CuZn-SOD was degraded by proteosomes at a 1.8-fold greater rate than the native protein (85).

In summary, an understanding of reversibility of protein Tyr nitration in the context of signal transduction mechanisms remains elusive. Although the evidence for denitrase activities in cells and mitochondria is compelling, conclusive proof will require identification of the denitrase proteins. The use of endogenously nitrated proteins with a defined nitrated Tyr or proteins “nitrated” by incorporation of nitroTyr during in vitro translation as substrates may be important in identifying denitrases as well as defining the physiological significance of selective proteolysis.

Conclusions

In this short review, we have attempted to provide experimental evidence suggesting that Tyr nitration under certain physiological conditions fulfills the criteria of a physiologically relevant signal in that it can be specific, reversible, occurs on a physiological time scale, and depending on a target, can result in either activation or inhibition. How specificity in nitration is defined biologically and mechanisms of reversibility in cellular systems are poorly understood. This is in part the result of how past studies have mostly focused on nitrated proteins that are either in high abundance, show a high degree of nitration or are nitrated under non-physiological conditions. As more investigations identify proteins involved in cell regulatory pathways in which nitration of only a small fraction of that protein pool is necessary to affect cell function, the underlying mechanisms of biological specificity and reversal of protein Tyr nitration should come into focus. This is becoming apparent in a number of recent studies demonstrating nitration of key regulatory proteins including p53 (47), IκBα (49), protein kinase C∊ (86), protein phosphatase 2A (87), β-catenin (88), histone deacetylase II (89), smooth muscle l-type calcium channel (81), ERK1/2 (90), and Akt (90,91).

Acknowledgments

Declaration of interest

The research of the authors cited has been funded by National Institutes of Health Grants 5RO1CA 90881 and PO1172955.

References

  • 1.Xu W, Charles IG, Moncada S. Nitric oxide: orchestrating hypoxia regulation through mitochondrial respiration and the endoplasmic reticulum stress response. Cell Res. 2005;15:63–65. doi: 10.1038/sj.cr.7290267. [DOI] [PubMed] [Google Scholar]
  • 2.Janssen-Heininger YM, Mossman BT, Heintz NH, Forman HJ, Kalyanaraman B, Finkel T, Stamler JS, Rhee SG, van der Vliet A. Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic Biol Med. 2008;45:1–17. doi: 10.1016/j.freeradbiomed.2008.03.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Forrester MT, Thompson JW, Foster MW, Nogueira L, Moseley MA, Stamler JS. Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture. Nat Biotechnol. 2009;27:557–559. doi: 10.1038/nbt.1545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol. 2005;6:150–166. doi: 10.1038/nrm1569. [DOI] [PubMed] [Google Scholar]
  • 5.Barrett DM, Black SM, Todor H, Schmidt-Ullrich RK, Dawson KS, Mikkelsen RB. Inhibition of protein-tyrosine phosphatases by mild oxidative stresses is dependent on S-nitrosylation. J Biol Chem. 2005;280:14453–14461. doi: 10.1074/jbc.M411523200. [DOI] [PubMed] [Google Scholar]
  • 6.Maejima Y, Adachi S, Morikawa K, Ito H, Isobe M. Nitric oxide inhibits myocardial apoptosis by preventing caspase-3 activity via S-nitrosylation. J Mol Cell Cardiol. 2005;38:163–174. doi: 10.1016/j.yjmcc.2004.10.012. [DOI] [PubMed] [Google Scholar]
  • 7.Mannick JB, Schonhoff C, Papeta N, Ghafourifar P, Szibor M, Fang K, Gaston B. S-Nitrosylation of mitochondrial caspases. J Cell Biol. 2001;154:1111–1116. doi: 10.1083/jcb.200104008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Marshall HE, Hess DT, Stamler JS. S-nitrosylation: physiological regulation of NF-kappaB. Proc Natl Acad Sci USA. 2004;101:8841–8842. doi: 10.1073/pnas.0403034101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Rössig L, Fichtlscherer B, Breitschopf K, Haendeler J, Zeiher AM, Mülsch A, Dimmeler S. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem. 1999;274:6823–6826. doi: 10.1074/jbc.274.11.6823. [DOI] [PubMed] [Google Scholar]
  • 10.Zhou P, Qian L, Iadecola C. Nitric oxide inhibits caspase activation and apoptotic morphology but does not rescue neuronal death. J Cereb Blood Flow Metab. 2005;25:348–357. doi: 10.1038/sj.jcbfm.9600036. [DOI] [PubMed] [Google Scholar]
  • 11.Sturla LM, Amorino G, Alexander MS, Mikkelsen RB, Valerie K, Schmidt-Ullrichr RK. Requirement of Tyr-992 and Tyr-1173 in phosphorylation of the epidermal growth factor receptor by ionizing radiation and modulation by SHP2. J Biol Chem. 2005;280:14597–14604. doi: 10.1074/jbc.M413287200. [DOI] [PubMed] [Google Scholar]
  • 12.Upmacis RK. Atherosclerosis: A Link Between Lipid Intake and Protein Tyrosine Nitration. Lipid Insights. 2008;2008:75. [PMC free article] [PubMed] [Google Scholar]
  • 13.Smith DJ. Mitochondrial dysfunction in mouse models of Parkinson's disease revealed by transcriptomics and proteomics. J Bioenerg Biomembr. 2009;41:487–491. doi: 10.1007/s10863-009-9254-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Reynolds MR, Berry RW, Binder LI. Nitration in neurodegeneration: deciphering the “Hows” “nYs”. Biochemistry. 2007;46:7325–7336. doi: 10.1021/bi700430y. [DOI] [PubMed] [Google Scholar]
  • 15.Reyes JF, Reynolds MR, Horowitz PM, Fu Y, Guillozet-Bongaarts AL, Berry R, Binder LI. A possible link between astrocyte activation and tau nitration in Alzheimer's disease. Neurobiol Dis. 2008;31:198–208. doi: 10.1016/j.nbd.2008.04.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Pieper GM, Ionova IA, Cooley BC, Migrino RQ, Khanna AK, Whitsett J, Vásquez-Vivar J. Sepiapterin decreases acute rejection and apoptosis in cardiac transplants independently of changes in nitric oxide and inducible nitric-oxide synthase dimerization. J Pharmacol Exp Ther. 2009;329:890–899. doi: 10.1124/jpet.108.148569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, Wang C, Fortina P, Addya S, Pestell RG, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the “reverse Warburg effect”: A transcriptional informatics analysis with validation. Cell Cycle. 2010;9:2201–2219. doi: 10.4161/cc.9.11.11848. [DOI] [PubMed] [Google Scholar]
  • 18.Naito Y, Takagi T, Okada H, Nukigi Y, Uchiyama K, Kuroda M, Handa O, Kokura S, Yagi N, Kato Y, Osawa T, Yoshikawa T. Expression of inducible nitric oxide synthase and nitric oxide-modified proteins in Helicobacter pylori-associated atrophic gastric mucosa. J Gastroenterol Hepatol. 2008;23(Suppl 2):S250–S257. doi: 10.1111/j.1440-1746.2008.05412.x. [DOI] [PubMed] [Google Scholar]
  • 19.Koeck T, Corbett JA, Crabb JW, Stuehr DJ, Aulak KS. Glucose-modulated tyrosine nitration in beta cells: targets and consequences. Arch Biochem Biophys. 2009;484:221–231. doi: 10.1016/j.abb.2009.01.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kang M, Ross GR, Akbarali HI. The effect of tyrosine nitration of L-type Ca2+ channels on excitation-transcription coupling in colonic inflammation. Br J Pharmacol. 2010;159:1226–1235. doi: 10.1111/j.1476-5381.2009.00599.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Jones LE, Jr, Ying L, Hofseth AB, Jelezcova E, Sobol RW, Ambs S, Harris CC, Espey MG, Hofseth LJ, Wyatt MD. Differential effects of reactive nitrogen species on DNA base excision repair initiated by the alkyladenine DNA glycosylase. Carcinogenesis. 2009;30:2123–2129. doi: 10.1093/carcin/bgp256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 2000;290:985–989. doi: 10.1126/science.290.5493.985. [DOI] [PubMed] [Google Scholar]
  • 23.Donnini S, Monti M, Roncone R, Morbidelli L, Rocchigiani M, Oliviero S, Casella L, Giachetti A, Schulz R, Ziche M. Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4. FEBS Lett. 2008;582:1135–1140. doi: 10.1016/j.febslet.2008.02.080. [DOI] [PubMed] [Google Scholar]
  • 24.Brindicci C, Kharitonov SA, Ito M, Elliott MW, Hogg JC, Barnes PJ, Ito K. Nitric oxide synthase isoenzyme expression and activity in peripheral lung tissue of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181:21–30. doi: 10.1164/rccm.200904-0493OC. [DOI] [PubMed] [Google Scholar]
  • 25.Blantz RC, Munger K. Role of nitric oxide in inflammatory conditions. Nephron. 2002;90:373–378. doi: 10.1159/000054723. [DOI] [PubMed] [Google Scholar]
  • 26.MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA. 1996;93:11853–11858. doi: 10.1073/pnas.93.21.11853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Zhang L, Chen CL, Kang PT, Garg V, Hu K, Green-Church KB, Chen YR. Peroxynitrite-mediated oxidative modifications of complex II: relevance in myocardial infarction. Biochemistry. 2010;49:2529–2539. doi: 10.1021/bi9018237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Reynolds MR, Berry RW, Binder LI. Site-specific nitration and oxidative dityrosine bridging of the tau protein by peroxynitrite: implications for Alzheimer's disease. Biochemistry. 2005;44:1690–1700. doi: 10.1021/bi047982v. [DOI] [PubMed] [Google Scholar]
  • 29.Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315–424. doi: 10.1152/physrev.00029.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Yu D, Neeley WL, Pritchard CD, Slotkin JR, Woodard EJ, Langer R, Teng YD. Blockade of peroxynitrite-induced neural stem cell death in the acutely injured spinal cord by drug-releasing polymer. Stem Cells. 2009;27:1212–1222. doi: 10.1002/stem.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Michniewicz M, Zago MK, Abas L, Weijers D, Schweighofer A, Meskiene I, Heisler MG, Ohno C, Zhang J, Huang F, Schwab R, Weigel D, Meyerowitz EM, Luschnig C, Offringa R, Friml J. Antagonistic regulation of PIN phosphorylation by PP2A and PINOID directs auxin flux. Cell. 2007;130:1044–1056. doi: 10.1016/j.cell.2007.07.033. [DOI] [PubMed] [Google Scholar]
  • 32.Shirakura T, Han F, Shiota N, Moriguchi S, Kasahara J, Sato T, Shirasaki Y, Fukunaga K. Inhibition of nitric oxide production and protein tyrosine nitration contribute to neuroprotection by a novel calmodulin antagonist, DY-9760e, in the rat microsphere embolism. Biol Pharm Bull. 2005;28:1658–1661. doi: 10.1248/bpb.28.1658. [DOI] [PubMed] [Google Scholar]
  • 33.Riganti C, Miraglia E, Viarisio D, Costamagna C, Pescarmona G, Ghigo D, Bosia A. Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux. Cancer Res. 2005;65:516–525. [PubMed] [Google Scholar]
  • 34.Peluffo G, Radi R. Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc Res. 2007;75:291–302. doi: 10.1016/j.cardiores.2007.04.024. [DOI] [PubMed] [Google Scholar]
  • 35.Kim JY, Jung KJ, Choi JS, Chung HY. Hesperetin: a potent antioxidant against peroxynitrite. Free Radic Res. 2004;38:761–769. doi: 10.1080/10715760410001713844. [DOI] [PubMed] [Google Scholar]
  • 36.Hooper DC, Scott GS, Zborek A, Mikheeva T, Kean RB, Koprowski H, Spitsin SV. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J. 2000;14:691–698. doi: 10.1096/fasebj.14.5.691. [DOI] [PubMed] [Google Scholar]
  • 37.Han F, Lu YM, Hasegawa H, Kanai H, Hachimura E, Shirasaki Y, Fukunaga K. Inhibition of dystrophin breakdown and endothelial nitric-oxide synthase uncoupling accounts for cytoprotection by 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e) in left ventricular hypertrophied Mice. J Pharmacol Exp Ther. 2010;332:421–428. doi: 10.1124/jpet.109.161646. [DOI] [PubMed] [Google Scholar]
  • 38.Gow AJ, Farkouh CR, Munson DA, Posencheg MA, Ischiropoulos H. Biological significance of nitric oxide-mediated protein modifications. Am J Physiol Lung Cell Mol Physiol. 2004;287:L262–L268. doi: 10.1152/ajplung.00295.2003. [DOI] [PubMed] [Google Scholar]
  • 39.Abdelsaid MA, Pillai BA, Matragoon S, Prakash R, Al-Shabrawey M, El-Remessy AB. Early intervention of tyrosine nitration prevents vaso-obliteration and neovascularization in ischemic retinopathy. J Pharmacol Exp Ther. 2010;332:125–134. doi: 10.1124/jpet.109.157941. [DOI] [PubMed] [Google Scholar]
  • 40.Zhang Y, Lu N, Gao Z. Hemin-H2O2-NO2(−) induced protein oxidation and tyrosine nitration are different from those of SIN-1: a study on glutamate dehydrogenase nitrative/oxidative modification. Int J Biochem Cell Biol. 2009;41:907–915. doi: 10.1016/j.biocel.2008.08.040. [DOI] [PubMed] [Google Scholar]
  • 41.Batthyány C, Souza JM, Durán R, Cassina A, Cerveñansky C, Radi R. Time course and site(s) of cytochrome c tyrosine nitration by peroxynitrite. Biochemistry. 2005;44:8038–8046. doi: 10.1021/bi0474620. [DOI] [PubMed] [Google Scholar]
  • 42.Sokolovsky M, Aviram I, Schejter A. Nitrocytochrome c. I. Structure and enzymic properties. Biochemistry. 1970;9:5113–5118. doi: 10.1021/bi00828a011. [DOI] [PubMed] [Google Scholar]
  • 43.Dairou J, Pluvinage B, Noiran J, Petit E, Vinh J, Haddad I, Mary J, Dupret JM, Rodrigues-Lima F. Nitration of a critical tyrosine residue in the allosteric inhibitor site of muscle glycogen phosphorylase impairs its catalytic activity. J Mol Biol. 2007;372:1009–1021. doi: 10.1016/j.jmb.2007.07.011. [DOI] [PubMed] [Google Scholar]
  • 44.Caruso C, Cacace MG, Di Prisco G. Chemical modification of phosphorylase b by tetranitromethane. Identification of a functional tyrosyl residue. Eur J Biochem. 1987;166:547–552. doi: 10.1111/j.1432-1033.1987.tb13548.x. [DOI] [PubMed] [Google Scholar]
  • 45.Lennon CW, Cox HD, Hennelly SP, Chelmo SJ, McGuirl MA. Probing structural differences in prion protein isoforms by tyrosine nitration. Biochemistry. 2007;46:4850–4860. doi: 10.1021/bi0617254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Aulak KS, Koeck T, Crabb JW, Stuehr DJ. Dynamics of protein nitration in cells and mitochondria. Am J Physiol Heart Circ Physiol. 2004;286:H30–H38. doi: 10.1152/ajpheart.00743.2003. [DOI] [PubMed] [Google Scholar]
  • 47.Yakovlev VA, Bayden AS, Graves PR, Kellogg GE, Mikkelsen RB. Nitration of the tumor suppressor protein p53 at tyrosine 327 promotes p53 oligomerization and activation. Biochemistry. 2010;49:5331–5339. doi: 10.1021/bi100564w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Lanone S, Manivet P, Callebert J, Launay JM, Payen D, Aubier M, Boczkowski J, Mebazaa A. Inducible nitric oxide synthase (NOS2) expressed in septic patients is nitrated on selected tyrosine residues: implications for enzymic activity. Biochem J. 2002;366:399–404. doi: 10.1042/BJ20020339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Yakovlev VA, Barani IJ, Rabender CS, Black SM, Leach JK, Graves PR, Kellogg GE, Mikkelsen RB. Tyrosine nitration of IkappaBalpha: a novel mechanism for NF-kappaB activation. Biochemistry. 2007;46:11671–11683. doi: 10.1021/bi701107z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Aslan M, Ryan TM, Townes TM, Coward L, Kirk MC, Barnes S, Alexander CB, Rosenfeld SS, Freeman BA. Nitric oxide-dependent generation of reactive species in sickle cell disease. Actin tyrosine induces defective cytoskeletal polymerization. J Biol Chem. 2003;278:4194–4204. doi: 10.1074/jbc.M208916200. [DOI] [PubMed] [Google Scholar]
  • 51.Kanski J, Hong SJ, Schöneich C. Proteomic analysis of protein nitration in aging skeletal muscle and identification of nitrotyrosine-containing sequences in vivo by nanoelectrospray ionization tandem mass spectrometry. J Biol Chem. 2005;280:24261–24266. doi: 10.1074/jbc.M501773200. [DOI] [PubMed] [Google Scholar]
  • 52.Grune T, Blasig IE, Sitte N, Roloff B, Haseloff R, Davies KJ. Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome. J Biol Chem. 1998;273:10857–10862. doi: 10.1074/jbc.273.18.10857. [DOI] [PubMed] [Google Scholar]
  • 53.Zheng L, Settle M, Brubaker G, Schmitt D, Hazen SL, Smith JD, Kinter M. Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages. J Biol Chem. 2005;280:38–47. doi: 10.1074/jbc.M407019200. [DOI] [PubMed] [Google Scholar]
  • 54.Sharov VS, Galeva NA, Kanski J, Williams TD, Schöneich C. Age-associated tyrosine nitration of rat skeletal muscle glycogen phosphorylase b: characterization by HPLC-nanoelectrospray-tandem mass spectrometry. Exp Gerontol. 2006;41:407–416. doi: 10.1016/j.exger.2006.02.012. [DOI] [PubMed] [Google Scholar]
  • 55.Abello N, Kerstjens HA, Postma DS, Bischoff R. Protein tyrosine nitration: selectivity, physicochemical and biological consequences, denitration, and proteomics methods for the identification of tyrosine-nitrated proteins. J Proteome Res. 2009;8:3222–3238. doi: 10.1021/pr900039c. [DOI] [PubMed] [Google Scholar]
  • 56.Ischiropoulos H. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem Biophys Res Commun. 2003;305:776–783. doi: 10.1016/s0006-291x(03)00814-3. [DOI] [PubMed] [Google Scholar]
  • 57.Souza JM, Daikhin E, Yudkoff M, Raman CS, Ischiropoulos H. Factors determining the selectivity of protein tyrosine nitration. Arch Biochem Biophys. 1999;371:169–178. doi: 10.1006/abbi.1999.1480. [DOI] [PubMed] [Google Scholar]
  • 58.Souza JM, Peluffo G, Radi R. Protein tyrosine nitration–functional alteration or just a biomarker? Free Radic Biol Med. 2008;45:357–366. doi: 10.1016/j.freeradbiomed.2008.04.010. [DOI] [PubMed] [Google Scholar]
  • 59.Elfering SL, Haynes VL, Traaseth NJ, Ettl A, Giulivi C. Aspects, mechanism, and biological relevance of mitochondrial protein nitration sustained by mitochondrial nitric oxide synthase. Am J Physiol Heart Circ Physiol. 2004;286:H22–H29. doi: 10.1152/ajpheart.00766.2003. [DOI] [PubMed] [Google Scholar]
  • 60.Sacksteder CA, Qian WJ, Knyushko TV, Wang H, Chin MH, Lacan G, Melega WP, Camp DG, 2nd, Smith RD, Smith DJ, Squier TC, Bigelow DJ. Endogenously nitrated proteins in mouse brain: links to neurodegenerative disease. Biochemistry. 2006;45:8009–8022. doi: 10.1021/bi060474w. [DOI] [PubMed] [Google Scholar]
  • 61.Stamler JS, Toone EJ, Lipton SA, Sucher NJ. (S)NO signals: translocation, regulation, and a consensus motif. Neuron. 1997;18:691–696. doi: 10.1016/s0896-6273(00)80310-4. [DOI] [PubMed] [Google Scholar]
  • 62.Pérez-Mato I, Castro C, Ruiz FA, Corrales FJ, Mato JM. Methionine adenosyltransferase S-nitrosylation is regulated by the basic and acidic amino acids surrounding the target thiol. J Biol Chem. 1999;274:17075–17079. doi: 10.1074/jbc.274.24.17075. [DOI] [PubMed] [Google Scholar]
  • 63.Li H, Kundu TK, Zweier JL. Characterization of the magnitude and mechanism of aldehyde oxidase-mediated nitric oxide production from nitrite. J Biol Chem. 2009;284:33850–33858. doi: 10.1074/jbc.M109.019125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Nohl H, Staniek K, Kozlov AV. The existence and significance of a mitochondrial nitrite reductase. Redox Rep. 2005;10:281–286. doi: 10.1179/135100005X83707. [DOI] [PubMed] [Google Scholar]
  • 65.Heijnen HF, van Donselaar E, Slot JW, Fries DM, Blachard-Fillion B, Hodara R, Lightfoot R, Polydoro M, Spielberg D, Thomson L, Regan EA, Crapo J, Ischiropoulos H. Subcellular localization of tyrosine-nitrated proteins is dictated by reactive oxygen species generating enzymes and by proximity to nitric oxide synthase. Free Radic Biol Med. 2006;40:1903–1913. doi: 10.1016/j.freeradbiomed.2005.09.006. [DOI] [PubMed] [Google Scholar]
  • 66.Zhao YY, Zhao YD, Mirza MK, Huang JH, Potula HH, Vogel SM, Brovkovych V, Yuan JX, Wharton J, Malik AB. Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. J Clin Invest. 2009;119:2009–2018. doi: 10.1172/JCI33338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Leach JK, Black SM, Schmidt-Ullrich RK, Mikkelsen RB. Activation of constitutive nitric-oxide synthase activity is an early signaling event induced by ionizing radiation. J Biol Chem. 2002;277:15400–15406. doi: 10.1074/jbc.M110309200. [DOI] [PubMed] [Google Scholar]
  • 68.Ichas F, Mazat JP. From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state. Biochim Biophys Acta. 1998;1366:33–50. doi: 10.1016/s0005-2728(98)00119-4. [DOI] [PubMed] [Google Scholar]
  • 69.Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med. 2000;192:1001–1014. doi: 10.1084/jem.192.7.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Leach JK, Van Tuyle G, Lin PS, Schmidt-Ullrich R, Mikkelsen RB. Ionizing radiation-induced, mitochondria-dependent generation of reactive oxygen/nitrogen. Cancer Res. 2001;61:3894–3901. [PubMed] [Google Scholar]
  • 71.Alp NJ, Channon KM. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol. 2004;24:413–420. doi: 10.1161/01.ATV.0000110785.96039.f6. [DOI] [PubMed] [Google Scholar]
  • 72.Mikkelsen RB, Wardman P. Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene. 2003;22:5734–5754. doi: 10.1038/sj.onc.1206663. [DOI] [PubMed] [Google Scholar]
  • 73.Stuehr D, Pou S, Rosen GM. Oxygen reduction by nitric-oxide synthases. J Biol Chem. 2001;276:14533–14536. doi: 10.1074/jbc.R100011200. [DOI] [PubMed] [Google Scholar]
  • 74.Song Y, Cardounel AJ, Zweier JL, Xia Y. Inhibition of superoxide generation from neuronal nitric oxide synthase by heat shock protein 90: implications in NOS regulation. Biochemistry. 2002;41:10616–10622. doi: 10.1021/bi026060u. [DOI] [PubMed] [Google Scholar]
  • 75.Durante W, Johnson FK, Johnson RA. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol. 2007;34:906–911. doi: 10.1111/j.1440-1681.2007.04638.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Toby IT, Chicoine LG, Cui H, Chen B, Nelin LD. Hypoxia-induced proliferation of human pulmonary microvascular endothelial cells depends on epidermal growth factor receptor tyrosine kinase activation. Am J Physiol Lung Cell Mol Physiol. 2010;298:L600–L606. doi: 10.1152/ajplung.00122.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Fiedler LR, Wojciak-Stothard B. The DDAH/ADMA pathway in the control of endothelial cell migration and angiogenesis. Biochem Soc Trans. 2009;37:1243–1247. doi: 10.1042/BST0371243. [DOI] [PubMed] [Google Scholar]
  • 78.Irie Y, Saeki M, Kamisaki Y, Martin E, Murad F. Histone H1.2 is a substrate for denitrase, an activity that reduces nitrotyrosine immunoreactivity in proteins. Proc Natl Acad Sci USA. 2003;100:5634–5639. doi: 10.1073/pnas.1131756100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Kamisaki Y, Wada K, Bian K, Balabanli B, Davis K, Martin E, Behbod F, Lee YC, Murad F. An activity in rat tissues that modifies nitrotyrosine-containing proteins. Proc Natl Acad Sci USA. 1998;95:11584–11589. doi: 10.1073/pnas.95.20.11584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Görg B, Qvartskhava N, Voss P, Grune T, Häussinger D, Schliess F. Reversible inhibition of mammalian glutamine synthetase by tyrosine nitration. FEBS Lett. 2007;581:84–90. doi: 10.1016/j.febslet.2006.11.081. [DOI] [PubMed] [Google Scholar]
  • 81.Kang M, Akbarali HI. Denitration of L-type calcium channel. FEBS Lett. 2008;582:3033–3036. doi: 10.1016/j.febslet.2008.07.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Smallwood HS, Lourette NM, Boschek CB, Bigelow DJ, Smith RD, Pasa-Tolic L, Squier TC. Identification of a denitrase activity against calmodulin in activated macrophages using high-field liquid chromatography–FTICR mass spectrometry. Biochemistry. 2007;46:10498–10505. doi: 10.1021/bi7009713. [DOI] [PubMed] [Google Scholar]
  • 83.Hoffmann A, Levchenko A, Scott ML, Baltimore D. The IkappaBNF-kappaB signaling module: temporal control and selective gene activation. Science. 2002;298:1241–1245. doi: 10.1126/science.1071914. [DOI] [PubMed] [Google Scholar]
  • 84.Koeck T, Fu X, Hazen SL, Crabb JW, Stuehr DJ, Aulak KS. Rapid and selective oxygen-regulated protein tyrosine denitration and nitration in mitochondria. J Biol Chem. 2004;279:27257–27262. doi: 10.1074/jbc.M401586200. [DOI] [PubMed] [Google Scholar]
  • 85.Souza JM, Choi I, Chen Q, Weisse M, Daikhin E, Yudkoff M, Obin M, Ara J, Horwitz J, Ischiropoulos H. Proteolytic degradation of tyrosine nitrated proteins. Arch Biochem Biophys. 2000;380:360–366. doi: 10.1006/abbi.2000.1940. [DOI] [PubMed] [Google Scholar]
  • 86.Balafanova Z, Bolli R, Zhang J, Zheng Y, Pass JM, Bhatnagar A, Tang XL, Wang O, Cardwell E, Ping P. Nitric oxide (NO) induces nitration of protein kinase Cepsilon (PKCepsilon), facilitating PKCepsilon translocation via enhanced PKCepsilon -RACK2 interactions: a novel mechanism of no-triggered activation of PKCepsilon. J Biol Chem. 2002;277:15021–15027. doi: 10.1074/jbc.M112451200. [DOI] [PubMed] [Google Scholar]
  • 87.Ohama T, Brautigan DL. Endotoxin conditioning induces VCP/p97-mediated and inducible nitric-oxide synthase-dependent Tyr284 nitration in protein phosphatase 2A. J Biol Chem. 2010;285:8711–8718. doi: 10.1074/jbc.M109.099788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Prévotat L, Filomenko R, Solary E, Jeannin JF, Bettaieb A. Nitric oxide-induced down-regulation of beta-catenin in colon cancer cells by a proteasome-independent specific pathway. Gastroenterology. 2006;131:1142–1152. doi: 10.1053/j.gastro.2006.07.017. [DOI] [PubMed] [Google Scholar]
  • 89.Ito K, Hanazawa T, Tomita K, Barnes PJ, Adcock IM. Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Commun. 2004;315:240–245. doi: 10.1016/j.bbrc.2004.01.046. [DOI] [PubMed] [Google Scholar]
  • 90.Csibi A, Communi D, Müller N, Bottari SP. Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms. PLoS ONE. 2010;5:e10070. doi: 10.1371/journal.pone.0010070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Monti M, Donnini S, Giachetti A, Mochly-Rosen D, Ziche M. deltaPKC inhibition or varepsilonPKC activation repairs endothelial vascular dysfunction by regulating eNOS post-translational modification. J Mol Cell Cardiol. 2010;48:746–756. doi: 10.1016/j.yjmcc.2009.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES